Abstract |
Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively acts on Na+ channels and delays atrial depolarization, was tried successfully.
|
Authors | Aditi Vaishnav, Avani Vaishnav, Yash Lokhandwala |
Journal | Indian heart journal
(Indian Heart J)
2014 Jan-Feb
Vol. 66
Issue 1
Pg. 115-8
ISSN: 2213-3763 [Electronic] India |
PMID | 24581108
(Publication Type: Case Reports, Journal Article, Review)
|
Copyright | Copyright © 2013 Cardiological Society of India. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Acetanilides
- Piperazines
- Ranolazine
|
Topics |
- Acetanilides
(administration & dosage)
- Atrial Fibrillation
(diagnosis, drug therapy, etiology)
- Cardiomyopathy, Hypertrophic
(complications, diagnosis)
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Electrocardiography
(methods)
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Piperazines
(administration & dosage)
- Ranolazine
- Recurrence
- Severity of Illness Index
- Treatment Outcome
|